István Gaudi

986 total citations
20 papers, 768 citations indexed

About

István Gaudi is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, István Gaudi has authored 20 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in István Gaudi's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). István Gaudi is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). István Gaudi collaborates with scholars based in Hungary, United States and Austria. István Gaudi's co-authors include Andrea Ladányi, Beáta Somlai, Zsuzsanna Fejôs, József Tı́már, Katalin Gilde, Anita Mohos, Judit Kiss, Gabriella Liszkay, Judit Dobos and Miklós Kásler and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Radiotherapy and Oncology.

In The Last Decade

István Gaudi

19 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
István Gaudi Hungary 11 569 551 115 48 41 20 768
Sofia M. Shea United States 7 474 0.8× 446 0.8× 171 1.5× 60 1.3× 38 0.9× 12 654
Naoki Kunii Japan 15 513 0.9× 768 1.4× 145 1.3× 27 0.6× 38 0.9× 19 1.0k
Emanuel Calenoff United States 9 189 0.3× 326 0.6× 209 1.8× 51 1.1× 15 0.4× 17 570
Felipe Gálvez‐Cancino Chile 11 286 0.5× 362 0.7× 136 1.2× 41 0.9× 55 1.3× 19 570
Rotem Feniger-Barish Israel 10 274 0.5× 259 0.5× 168 1.5× 32 0.7× 67 1.6× 10 493
Sharon A. Oldford Canada 10 131 0.2× 384 0.7× 132 1.1× 53 1.1× 42 1.0× 14 502
Xuan Shao China 9 195 0.3× 259 0.5× 121 1.1× 49 1.0× 76 1.9× 15 471
Trine Øllegaard Jensen Denmark 4 309 0.5× 376 0.7× 129 1.1× 51 1.1× 38 0.9× 4 539
Patricia Marchal France 8 89 0.2× 179 0.3× 212 1.8× 26 0.5× 40 1.0× 11 462
Christine Pai United States 7 250 0.4× 315 0.6× 166 1.4× 15 0.3× 29 0.7× 10 533

Countries citing papers authored by István Gaudi

Since Specialization
Citations

This map shows the geographic impact of István Gaudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Gaudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Gaudi more than expected).

Fields of papers citing papers by István Gaudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by István Gaudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Gaudi. The network helps show where István Gaudi may publish in the future.

Co-authorship network of co-authors of István Gaudi

This figure shows the co-authorship network connecting the top 25 collaborators of István Gaudi. A scholar is included among the top collaborators of István Gaudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with István Gaudi. István Gaudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mohos, Anita, Eszter Papp, Gabriella Liszkay, et al.. (2017). Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy. Cancer Immunology Immunotherapy. 67(1). 141–151. 68 indexed citations
3.
4.
Somlai, Beáta, et al.. (2012). Melanoma Screening in a Hungarian Nuclear Power Plant. Pathology & Oncology Research. 19(2). 323–328. 3 indexed citations
5.
Tóth, Erika, József Lövey, Zsuzsanna Molnár, et al.. (2011). Standard CHOP immuno-chemotherapy of primary mediastinal lymphomas. Orvosi Hetilap. 152(19). 735–742. 1 indexed citations
6.
Ladányi, Andrea, Judit Kiss, Anita Mohos, et al.. (2011). Prognostic impact of B-cell density in cutaneous melanoma. Cancer Immunology Immunotherapy. 60(12). 1729–1738. 138 indexed citations
7.
Ladányi, Andrea, Anita Mohos, Beáta Somlai, et al.. (2010). FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma. Pathology & Oncology Research. 16(3). 303–309. 48 indexed citations
8.
Tusnády, Gábor, István Gaudi, Lídia Rejtö, Miklós Kásler, & Zoltán Szentirmay. (2008). A magyar daganatos betegek túlélési esélye a Nemzeti Rákregiszter adatai alapján. PubMed. 52(4). 339–349. 13 indexed citations
9.
Kiss, Judit, József Tı́már, Beáta Somlai, et al.. (2007). Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma. Pathology & Oncology Research. 13(1). 21–31. 27 indexed citations
10.
Ladányi, Andrea, Judit Kiss, Beáta Somlai, et al.. (2007). Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunology Immunotherapy. 56(9). 1459–1469. 219 indexed citations
11.
Remenár, Éva, et al.. (2007). Increase of hypophyseal hormone levels in male head and neck cancer patients. Pathology & Oncology Research. 13(4). 341–344. 7 indexed citations
12.
13.
Géczi, Lajos, et al.. (2006). [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].. PubMed. 50(4). 329–35. 2 indexed citations
14.
Géczi, Lajos, et al.. (2005). Characteristics and risk factors of cisplatin induced ototoxicity in testicular cancer patients, detected by distortion product otoacustic emmision (DPOAE). Journal of Clinical Oncology. 23(16_suppl). 4578–4578. 2 indexed citations
15.
Ladányi, Andrea, Beáta Somlai, Katalin Gilde, et al.. (2004). T-Cell Activation Marker Expression on Tumor-Infiltrating Lymphocytes As Prognostic Factor in Cutaneous Malignant Melanoma. Clinical Cancer Research. 10(2). 521–530. 127 indexed citations
16.
Gaudi, István & Miklós Kásler. (2003). [New cases of melanoma as documented in the National Cancer Registry].. PubMed. 47(1). 13–7. 4 indexed citations
17.
Remenár, Éva, Barna Budai, Zsolt Orosz, et al.. (2003). [Prognostic significance of sex steroid and hypophyseal hormones in head and neck squamous cell carcinoma].. PubMed. 47(2). 155–9. 3 indexed citations
18.
Gaudi, István & Miklós Kásler. (2002). [The course of cancer mortality in Hungary between 1975 and 2001].. PubMed. 46(4). 291–5. 7 indexed citations
19.
Remenár, Éva, et al.. (2002). [Serum levels of sex steroid and pituitary hormones in chronic alcoholics and head and neck cancer patients as compared to normal controls].. PubMed. 46(4). 329–32. 3 indexed citations
20.
Ésik, Olga, Wolfgang Seitz, József Lövey, et al.. (1999). External audit on the clinical practice and medical decision-making at the departments of radiotherapy in Budapest and Vienna. Radiotherapy and Oncology. 51(1). 87–94. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia M. Shea Breakdown of academic impact, for papers by Naoki Kunii Breakdown of academic impact, for papers by Emanuel Calenoff Breakdown of academic impact, for papers by Felipe Gálvez‐Cancino Breakdown of academic impact, for papers by Rotem Feniger-Barish Breakdown of academic impact, for papers by Sharon A. Oldford Breakdown of academic impact, for papers by Xuan Shao Breakdown of academic impact, for papers by Trine Øllegaard Jensen Breakdown of academic impact, for papers by Patricia Marchal Breakdown of academic impact, for papers by Christine Pai
Rankless by CCL
2026